Obeticholic Acid/Bezafibrate
- Generic Name
- Obeticholic Acid/Bezafibrate
Fixed Dose Combination Drug (Polypill)for Secondary Cardiovascular Prevention.
Phase 3
Completed
- Conditions
- Myocardial Infarction
- Interventions
- Drug: Separately drugs, simvastatin, aspirin and ramipril
- First Posted Date
- 2011-03-23
- Last Posted Date
- 2014-07-15
- Lead Sponsor
- Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III
- Target Recruit Count
- 2118
- Registration Number
- NCT01321255
- Locations
- 🇪🇸
Hospital Virgen Macarena, Sevilla, Spain
🇦🇷DIM Clínica Privada, Ramos Mejía, Argentina
🇮🇹Ospedale F. Veneziale, Isernia, Italy
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath